Method Transfer from Agilent 1100 Series LC System to the ACQUITY UPLC H-Class System: The Effect of Temperature

Technical notes | 2014 | WatersInstrumentation
HPLC
Industries
Manufacturer
Agilent Technologies, Waters

Summary

Importance of the Topic


Analytical laboratories frequently face the challenge of transferring high-performance liquid chromatography (HPLC) methods across systems from different manufacturers. Temperature control plays a critical role in separation selectivity and retention, and differences in heating mechanisms can compromise method fidelity. Addressing temperature effects during transfer reduces redevelopment costs and downtime.

Study Aims and Overview


This study demonstrates successful transfer of an analgesic separation method from an Agilent 1100 Series LC System to a Waters ACQUITY UPLC H-Class System (CH-A compartment). The objective was to evaluate retention time comparability and selectivity over 36–60 °C, both with and without mobile phase pre-heating.

Methodology and Instrumentation


The transfer protocol involved measuring dwell volumes on each system and entering gradient delay via SmartStart Technology on the UPLC. Analyses were conducted at temperature intervals between 36 °C and 60 °C. Two configurations were tested: one employing mobile phase pre-heating and another bypassing pre-heating circuitry.

Used Instrumentation


  • Agilent 1100 Series LC System with passive 3 µL pre-heater
  • Waters ACQUITY UPLC H-Class System with active column compartment pre-heater and SmartStart gradient delay
  • Identical analytical column chemistry and mobile phase composition on both systems

Results and Discussion


Retention times for seven analgesic compounds were comparable between the two systems over the full temperature range. With pre-heating, both systems exhibited a stronger decrease in retention time as temperature increased, and selectivity shifts for phenacetin and salicylic acid were observed at 2 °C intervals. Without pre-heating, retention time trends remained parallel, but selectivity changes above 42 °C were abolished. These findings highlight that mobile phase pre-heating can enhance temperature sensitivity but is not essential for baseline method transfer.

Benefits and Practical Applications


The demonstrated transfer enables laboratories to leverage existing HPLC methods on modern UPLC platforms without extensive revalidation. Consideration of temperature control options allows analysts to maintain method performance, improve throughput, and minimize instrument investment.

Future Trends and Applications


Advances in column thermostat design and active mobile phase heating promise even finer temperature regulation and selectivity control. Integration of predictive modelling and machine learning could further streamline method transfer across diverse chromatographic systems. Adoption of standardized temperature transfer protocols will enhance reproducibility in pharmaceutical and industrial analytics.

Conclusion


Successful method transfer from an Agilent 1100 Series LC System to an ACQUITY UPLC H-Class System was achieved with consistent retention and selectivity profiles. Temperature control, particularly mobile phase pre-heating, influences selectivity behavior and should be considered during method migration.

References


  1. Chapter 621 Chromatography. United States Pharmacopeia and National Formulary (USP 30-NF 32 SR2), United Book Press, Inc., 2013, pp. 6376-6385.
  2. Protocol for Gradient Delay (Dwell Volume) Measurement. Transferring Compendial HPLC Methods to UPLC Technology. Waters Corporation Application Notebook, 2013, pp. 67-68.
  3. Gradient SmartStart. ACQUITY UPLC H-Class System Guide Revision B. Waters Corporation, 2010, pp. 5-6.
  4. Schrenker H. Effect of mobile phase pre-heating on high-performance liquid chromatographic column performance: A new type of column thermostat. J Chromatogr A. 1981;213:243-252.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Transfer of an Isocratic USP Assay from an Agilent 1100 Series LC System to a ACQUITY UPLC H-Class System: Analysis of Tioconazole and Related Impurities
Transfer of an Isocratic USP Assay from an Agilent 1100 Series LC System to a ACQUITY UPLC H-Class System: Analysis of Tioconazole and Related Impurities Paula Hong and Patricia R. McConville Waters Corporation, Milford, MA G OA L USP methods…
Key words
tioconazole, tioconazoleusp, usprelated, relatedcompound, compounduplc, uplcsystem, systemacquity, acquityclass, classimpurities, impuritieshplc, hplcmonograph, monographsuitability, suitabilitydeviation, deviationmethods, methodsrequirements
Using Gradient SmartStart Technology and an ACQUITY UPLC H-Class System to Emulate an Agilent 1100 Series LC System Separation for Impurity Testing
Using Gradient SmartStart Technology and an ACQUITY UPLC H-Class System to Emulate an Agilent 1100 Series LC System Separation for Impurity Testing Paula Hong and Patricia R. McConville Waters Corporation, Milford, MA, USA A P P L I C AT…
Key words
smartstart, smartstartacquity, acquityuplc, uplcclass, classsystem, systemretention, retentiongradient, gradientclozapine, clozapinedwell, dwellrelative, relativetime, timecompound, compoundvolume, volumedelay, delaydelta
Method Transfer from an Agilent 1100 Series LC System to an ACQUITY UPLC H-Class System with Gradient SmartStart Technology: Analysis of an Active Pharmaceutical Ingredient and Related Substances
Method Transfer from an Agilent 1100 Series LC System to an ACQUITY UPLC H-Class System with Gradient SmartStart Technology: Analysis of an Active Pharmaceutical Ingredient and Related Substances Paula Hong and Patricia R. McConville G OA L Facilitate methods transfer…
Key words
uplc, uplcacquity, acquityclass, classabacavir, abacavirdeviation, deviationsmartstart, smartstartsystem, systemrsd, rsdgradient, gradientrelated, relatedsubstances, substancestransfer, transfermethod, methodretention, retentioninstrument
APPLICATION NOTEBOOK - IMPURITIES - Developing Safe and Effective Drugs
[ APPLICATION NOTEBOOK ] IMPURITIES Developing Safe and Effective Drugs INT RODUCTION NAVIGATION T he pharmaceutical industry is integral in maintaining public health by providing therapeutic and preventative medicines. T he cornerstones of bringing new medicines to market are quality,…
Key words
home, homeuplc, uplcimpurities, impuritiesziprasidone, ziprasidoneusp, uspacquity, acquityimpurity, impuritymethod, methodtioconazole, tioconazoleminutes, minutessimvastatin, simvastatinhplc, hplcusing, usingrelated, relatedanalysis
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike